Add to ORKGLong-term safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate-to-severe chronic cancer pai
Background: Oxycodone-naloxone (OXN) aims to reduce opioid-related constipation while being successf...
BACKGROUND: Oxycodone-Naloxone (OXN) aims to reduce opioid-related constipation while being successf...
Safety and tolerability of controlled-release oxycodone on postoperative pain in patients submitted ...
A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the s...
A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the s...
Efficacy and tolerability of low-dose oral prolonged-release oxycodone/naloxone for chronic nononcol...
Use of naloxone for reversal of life-threatening opioid toxicity in cancer-related pai
Objective: An examination of whether oxycodone/naloxone prolonged-release tablets (OXN PR) can impro...
Background: A prolonged-release formulation of oxycodone/naloxone has been shown to be effective in ...
Oxycodone is a valued opioid analgesic, which may be administered either as the first strong opioid ...
Fabio Guerriero,1,2 Anna Roberto,3 Maria Teresa Greco,4 Carmelo Sgarlata,1 Marco Rollone,2 Oscar Cor...
Background: Oxycodone-naloxone (OXN) aims to reduce opioid-related constipation while being successf...
Background: Oxycodone-naloxone (OXN) aims to reduce opioid-related constipation while being successf...
Background: Oxycodone-naloxone (OXN) aims to reduce opioid-related constipation while being successf...
Opioids provide effective relief from moderate-to-severe pain and should be prescribed as part of a ...
Background: Oxycodone-naloxone (OXN) aims to reduce opioid-related constipation while being successf...
BACKGROUND: Oxycodone-Naloxone (OXN) aims to reduce opioid-related constipation while being successf...
Safety and tolerability of controlled-release oxycodone on postoperative pain in patients submitted ...
A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the s...
A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the s...
Efficacy and tolerability of low-dose oral prolonged-release oxycodone/naloxone for chronic nononcol...
Use of naloxone for reversal of life-threatening opioid toxicity in cancer-related pai
Objective: An examination of whether oxycodone/naloxone prolonged-release tablets (OXN PR) can impro...
Background: A prolonged-release formulation of oxycodone/naloxone has been shown to be effective in ...
Oxycodone is a valued opioid analgesic, which may be administered either as the first strong opioid ...
Fabio Guerriero,1,2 Anna Roberto,3 Maria Teresa Greco,4 Carmelo Sgarlata,1 Marco Rollone,2 Oscar Cor...
Background: Oxycodone-naloxone (OXN) aims to reduce opioid-related constipation while being successf...
Background: Oxycodone-naloxone (OXN) aims to reduce opioid-related constipation while being successf...
Background: Oxycodone-naloxone (OXN) aims to reduce opioid-related constipation while being successf...
Opioids provide effective relief from moderate-to-severe pain and should be prescribed as part of a ...
Background: Oxycodone-naloxone (OXN) aims to reduce opioid-related constipation while being successf...
BACKGROUND: Oxycodone-Naloxone (OXN) aims to reduce opioid-related constipation while being successf...
Safety and tolerability of controlled-release oxycodone on postoperative pain in patients submitted ...